drugset

drugset / Trial / NCT06951334

Clinical Trial of Vildagliptin in Early Parkinson's Disease

NCT06951334 ↗

Not yet recruiting 66 enrolled First Affiliated Hospital, Sun Yat-Sen University

RandomizedParallel-groupSingle-blindTreatment

Summary

Investigating the efficacy of Vildagliptin in delaying the progression of Parkinson's disease.

Timeline

Start: 2025-06-01
Primary completion: 2026-12-31
Completion: 2026-12-31

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Vildagliptin	Other / unclassified	50 mg	—

Indications